![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Taylor & Francis Ltd
ISSN: 1054-3406
Source: Journal of Biopharmaceutical Statistics, Vol.24, Iss.3, 2014-05, pp. : 660-684
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Journal of Biopharmaceutical Statistics, Vol. 21, Iss. 3, 2011-05 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
High-dose aspirin appears to be associated with a high rate of haemorrhagic events
Inpharma, Vol. 1, Iss. 1509, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase I oncology trials: risks and benefits vary by trial type
Reactions Weekly, Vol. 1, Iss. 1042, 2005-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Phase I oncology trials: risks and benefits vary by trial type
Inpharma, Vol. 1, Iss. 1478, 2005-01 ,pp. :